Int J Rheum Dis. 2025 Dec;28(12):e70522. doi: 10.1111/1756-185x.70522. NO ABSTRACT PMID:41416762 | DOI:10.1111/1756-185x.70522
Mod Rheumatol Case Rep. 2025 Dec 19:rxaf084. doi: 10.1093/mrcr/rxaf084. Online ahead of print. ABSTRACT Granulomatosis with polyangiitis (GPA) is a
Biomater Sci. 2025 Dec 19. doi: 10.1039/d5bm01168j. Online ahead of print. ABSTRACT Psoriasis has been successfully treated by directly blocking
… rheumatic fever and rheumatic heart disease. Published Saturday in PLOS One Global Health, the Missing Piece Surveillance Study found
Five Fractures You Don’t Want to Miss In orthopedic practice, missing the wrong fracture can significantly alter a p https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
… rheumatology of the University of Pittsburgh Medical Center, said in a statement. “Furthermore, the improvements in patients’ disease activity …
Faecal microbiota transplantation from patients with fibromyalgia induced pain and immune activation in germ-free mice, highlighting the gut–immune– …
During chronic inflammation, fibroblasts orchestrate immune cell responses. They can acquire specific effector phenotypes that directly contribute to …
CHICAGO — Neuroimmune modulation could be an “emerging therapeutic approach” for patients with rheumatoid arthritis who had incomplete response or
Rheumato, Vol. 6, Pages 1: Decline in Renal Function, Measured by Annual Estimated Glomerular Filtration Rate Based on Cystatin C
Conditions: Rheumatoid Arthritis (RA Interventions: Device: Active treatment; Device: Sham (No Treatment) Sponsors: Surf Therapeutics Not yet recruiting
Nature Reviews Rheumatology, Published online: 19 December 2025; doi:10.1038/s41584-025-01344-4 Fibromyalgia remains a challenge for researchers and clinicians. Three studies published
CHICAGO — Neuroimmune modulation inhibited progression of structural damage in patients with rheumatoid arthritis who had inadequate response or intolerance
It was published online on November 26, 2025, in ACR Open Rheumatology. LIMITATIONS: The study enrolled only one third of
… rheumatic diseases such as systemic sclerosis and lupus erythematosus. … Dr Thorsten Witte from the Department of Rheumatology and
Lilly announced phase 3 RCT TRIUMPH-4, where Retatrutide, a new GIP, GLP-1 & glucagon recpt agonist, was given to o
Test your knowledge with Rheumatology Advisor’s latest clinical quiz on the current FDA-approved biosimilars.
A systematic review and meta-analysis published in Rheumatology … Rheumatology Waitlists: Applying Solutions Amid Healthcare System …
Three Things to Know About Hiring, Onboarding, and Training APPs cayla.alexande… Fri, 12/19/2025 – 08:00
… rheumatology at Stanford. … rheumatology at Stanford University, told Healio. “It highlights EBV-infected B cells as a potential disease …
Mol Med Rep. 2026 Feb;33(2):72. doi: 10.3892/mmr.2025.13782. Epub 2025 Dec 19. ABSTRACT Aberrant expression of microRNAs (miRNAs) has been closely
Future Cardiol. 2025 Dec 19:1-16. doi: 10.1080/14796678.2025.2603895. Online ahead of print. ABSTRACT Sjögren’s disease (SjD) is a systemic autoimmune disease
J Clin Aesthet Dermatol. 2025 Sep;18(9):22-25. ABSTRACT OBJECTIVE: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with systemic
Front Psychiatry. 2025 Dec 3;16:1695158. doi: 10.3389/fpsyt.2025.1695158. eCollection 2025. ABSTRACT BACKGROUND: Bipolar disorder is a chronic psychiatric condition characterized by
J Clin Aesthet Dermatol. 2025 Oct;18(10):40-47. ABSTRACT Cutaneous lupus erythematosus (CLE) may occur independently or in association with systemic lupus
J Grad Med Educ. 2025 Dec;17(6):779. doi: 10.4300/JGME-D-25-00176.1. Epub 2025 Dec 16. ABSTRACT Visual Abstract. PMID:41415983 | PMC:PMC12710375 | DOI:10.4300/JGME-D-25-00176.1
Clin Case Rep. 2025 Dec 17;13(12):e71700. doi: 10.1002/ccr3.71700. eCollection 2025 Dec. ABSTRACT Takayasu arteritis (TAK) is a rare large-vessel vasculitis
